178 related articles for article (PubMed ID: 27764235)
1. Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.
Cox CV; Diamanti P; Moppett JP; Blair A
PLoS One; 2016; 11(10):e0165210. PubMed ID: 27764235
[TBL] [Abstract][Full Text] [Related]
2. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
Terada T
Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia.
Cox CV; Martin HM; Kearns PR; Virgo P; Evely RS; Blair A
Blood; 2007 Jan; 109(2):674-82. PubMed ID: 17003368
[TBL] [Abstract][Full Text] [Related]
5. CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity.
Shi J; Zhang Z; Cen H; Wu H; Zhang S; Liu J; Leng Y; Ren A; Liu X; Zhang Z; Tong X; Liang J; Li Z; Zhou F; Huang L; Qin Y; Yang K; Zhang T; Zhu H
J Hematol Oncol; 2021 Oct; 14(1):162. PubMed ID: 34627328
[TBL] [Abstract][Full Text] [Related]
6. CD99 is a therapeutic target on disease stem cells in myeloid malignancies.
Chung SS; Eng WS; Hu W; Khalaj M; Garrett-Bakelman FE; Tavakkoli M; Levine RL; Carroll M; Klimek VM; Melnick AM; Park CY
Sci Transl Med; 2017 Jan; 9(374):. PubMed ID: 28123069
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.
Gerby B; Clappier E; Armstrong F; Deswarte C; Calvo J; Poglio S; Soulier J; Boissel N; Leblanc T; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
Leukemia; 2011 Aug; 25(8):1249-58. PubMed ID: 21566655
[TBL] [Abstract][Full Text] [Related]
8. T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells.
De Smedt M; Leclercq G; Vandekerckhove B; Kerre T; Taghon T; Plum J
Haematologica; 2011 May; 96(5):646-54. PubMed ID: 21330325
[TBL] [Abstract][Full Text] [Related]
9. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
[TBL] [Abstract][Full Text] [Related]
10. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
Soslow RA; Bhargava V; Warnke RA
Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
[TBL] [Abstract][Full Text] [Related]
11. High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia.
Romero LA; Hattori T; Ali MAE; Ketavarapu G; Koide A; Park CY; Koide S
J Mol Biol; 2022 Mar; 434(5):167402. PubMed ID: 34958778
[TBL] [Abstract][Full Text] [Related]
12. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.
George AA; Franklin J; Kerkof K; Shah AJ; Price M; Tsark E; Bockstoce D; Yao D; Hart N; Carcich S; Parkman R; Crooks GM; Weinberg K
Blood; 2001 Jun; 97(12):3925-30. PubMed ID: 11389036
[TBL] [Abstract][Full Text] [Related]
13. CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migration.
Imbert AM; Belaaloui G; Bardin F; Tonnelle C; Lopez M; Chabannon C
Blood; 2006 Oct; 108(8):2578-86. PubMed ID: 16825498
[TBL] [Abstract][Full Text] [Related]
14. RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.
Snauwaert S; Vanhee S; Goetgeluk G; Verstichel G; Van Caeneghem Y; Velghe I; Philippé J; Berneman ZN; Plum J; Taghon T; Leclercq G; Thielemans K; Kerre T; Vandekerckhove B
Haematologica; 2012 Oct; 97(10):1539-47. PubMed ID: 22532518
[TBL] [Abstract][Full Text] [Related]
15. CD99 (MIC2) expression in paediatric B-lineage leukaemia/lymphoma reflects maturation-associated patterns of normal B-lymphopoiesis.
Dworzak MN; Fritsch G; Fleischer C; Printz D; Fröschl G; Buchinger P; Mann G; Gadner H
Br J Haematol; 1999 Jun; 105(3):690-5. PubMed ID: 10354133
[TBL] [Abstract][Full Text] [Related]
16. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential.
Schmitt C; Ktorza S; Sarun S; Blanc C; De Jong R; Debre P
Blood; 1993 Dec; 82(12):3675-85. PubMed ID: 7505122
[TBL] [Abstract][Full Text] [Related]
17. CD99 antibody disrupts T-cell acute lymphoblastic leukemia adhesion to meningeal cells and attenuates chemoresistance.
Ebadi M; Jonart LM; Ostergaard J; Gordon PM
Sci Rep; 2021 Dec; 11(1):24374. PubMed ID: 34934147
[TBL] [Abstract][Full Text] [Related]
18. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F
Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041
[TBL] [Abstract][Full Text] [Related]
19. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
le Viseur C; Hotfilder M; Bomken S; Wilson K; Röttgers S; Schrauder A; Rosemann A; Irving J; Stam RW; Shultz LD; Harbott J; Jürgens H; Schrappe M; Pieters R; Vormoor J
Cancer Cell; 2008 Jul; 14(1):47-58. PubMed ID: 18598943
[TBL] [Abstract][Full Text] [Related]
20. Sex- and species-specific contribution of CD99 to T cell costimulation during multiple sclerosis.
Winschel I; Willing A; Engler JB; Walkenhorst M; Meurs N; Binkle-Ladisch L; Woo MS; Pfeffer LK; Sonner JK; Borgmeyer U; Hagen SH; Grünhagel B; Claussen JM; Altfeld M; Friese MA
Biol Sex Differ; 2024 May; 15(1):41. PubMed ID: 38750588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
